The Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study

Sponsor
National Eye Institute (NEI) (NIH)
Overall Status
Unknown status
CT.gov ID
NCT00000155
Collaborator
(none)
14

Study Details

Study Description

Brief Summary

To describe the clinical course of keratoconus and to describe the relationships among its visual and physiological manifestations, including high- and low-contrast visual acuity, corneal curvature, slit lamp biomicroscopic findings, corneal scarring, and quality of life.

To identify risk factors and protective factors that influence the severity and progression of keratoconus.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Keratoconus is a bilateral, asymmetric, chronic, progressive ectasia of the cornea characterized by steepening and distortion of the cornea, thinning of the apical cornea, corneal scarring, and treatment-related sequelae, such as abrasions from contact lenses and surgical complications. Patients experience distorted vision that worsens with disease progression. Their vision is typically corrected with spectacles early in the disease and, later, with rigid contact lenses. Some patients eventually undergo corneal transplantation in one or both eyes. Keratoconus affects people in their prime earning years and profoundly affects their lives.

    Previous large-scale studies of keratoconus have focused on incidence and prevalence, etiologies, or the clinical management of keratoconus. Few have characterized the course of the disease and risk factors for its progression in large samples of keratoconus patients. The incidence of vision-threatening corneal scarring in keratoconus is unknown. Patient's most frequent questions--how rapidly their keratoconus will progress, how bad their vision will become, whether they will need corneal surgery, how successful their contact lenses will be--cannot be answered on the basis of the current body of knowledge.

    The need for a prospective, observational study of keratoconus patients is great. Results from this study will address keratoconus patient's unanswered questions and will enable eye care practitioners to manage this complex ocular disease better.

    The Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study is a multicenter, observational study of 1,209 keratoconus patients followed for 3 years.

    Patients are examined annually. Study measures include visual acuity, patient-reported quality of life, manifest refraction, keratometry, photodocumentation of the cornea to identify central corneal scarring, photodocumentation of the flattest contact lens that just clears the cornea, slit lamp biomicroscopy, and corneal topography. In rigid contact lens wearers, the fluorescein pattern of the patient's habitual contact lenses is photodocumented.

    Patients are examined at 15 clinical centers. The clinical centers enrolled 1,209 patients in 12 months.

    Study Design

    Study Type:
    Observational
    Time Perspective:
    Prospective
    Study Start Date :
    Jun 1, 1995

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      12 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No

      Patients with keratoconus were eligible if they were at least 12 years old; had an irregular cornea as determined by keratometry, retinoscopy, or direct ophthalmoscopy in at least one eye; had Vogt's striae, Fleischer's ring, or corneal scarring characteristic of keratoconus in at least one eye; and planned to stay in the area for at least 3 years. They were ineligible if they had bilateral corneal transplants or bilateral nonkeratoconic eye disease (cataract, intraocular lenses, macular disease, or optic nerve disease other than glaucoma).

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 University of California, Berkeley, School of Optometry Berkeley California United States 94720-2020
      2 Southern California College of Optometry Fullerton California United States 92831
      3 Jules Stein Eye Institute, University of California at Los Angeles Los Angeles California United States 90095-7003
      4 Nova Southeastern University, Health Professions Division, College of Optometry Ft. Lauderdale Florida United States 33328
      5 University of Illinois at Chicago, Department of Ophthalmology and Visual Sciences Chicago Illinois United States 60612
      6 Indiana University, School of Optometry Bloomington Indiana United States 47405-3680
      7 University of Missouri-St. Louis, School of Optometry St. Louis Missouri United States 63121
      8 SUNY State College of Optometry New York New York United States 10036-8003
      9 University Hospitals of Cleveland, Department of Ophthalmology Cleveland Ohio United States 44106
      10 The Ohio State University, College of Optometry Columbus Ohio United States 43210-1240
      11 Pennsylvania College of Optometry, The Eye Institute Philadelphia Pennsylvania United States 19141
      12 Northeastern Eye Institute Scranton Pennsylvania United States 18503
      13 University of Utah, John Moran Eye Center Salt Lake City Utah United States 84132
      14 Gundersen Lutheran La Crosse Wisconsin United States 54601

      Sponsors and Collaborators

      • National Eye Institute (NEI)

      Investigators

      None specified.

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00000155
      Other Study ID Numbers:
      • NEI-57
      First Posted:
      Sep 24, 1999
      Last Update Posted:
      Jun 24, 2005
      Last Verified:
      Nov 1, 2001
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of Jun 24, 2005